
|Articles|July 9, 2018
Takeda Opens New Global Headquarters
Author(s)BioPharm International Editors
The company opened its new global headquarters in Japan.
Advertisement
Takeda Pharmaceutical announced the opening of its new headquarters in Nihonbashi, Tokyo on July 2, 2018. The building was completed in March 2018.
The company announced that it agreed to sell its previous Tokyo headquarters as well as its Shin-Edobashi building to Takashimaya Company in
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
2
FAQ: What You Need to Know About Agentic AI in Drug Discovery
3
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
4
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
5




